CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Ibnsina Pharma Co SAE is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Ibnsina Pharma Co SAE
Industrial Zone 1,
PO Box 91
Phone: +20 244891102p:+20 244891102 6TH OF OCTOBER CITY, Egypt Ticker: ISPHISPH
Business Summary
Ibnsina Pharma Co is an Egypt-based pharmaceutical distribution company. The Company distributes a portfolio of pharmaceutical products from over 350 Egyptian and multinational companies to more than 35,000 customers including pharmacies, hospitals, retail outlets, and wholesalers. Ibnsina Pharma Co's nationwide distribution network with more than 50 operational sites, including distribution hubs and central warehouses, is supported by a fleet of approximately 600 vehicles. The Company's main services for suppliers include management of warehousing and logistics for pharmaceutical products as well as the development and execution of tailored marketing solutions targeting a nationwide database of customers.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board AbdelAziz Ali
Co-Chief Executive Officer, Co-Founder, Executive Director MahmoudAbdel Gawad
Co-Chief Executive Officer, Co-Founder, Executive Director OmarAbdel Gawad
9 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 1,008,000,000 (As of 12/31/2023)
Stock Exchange: CAI
Fax Number: +20 244891137


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, April 22, 2024